Palatin Technologies - enormes Kurspotential
Seite 5 von 22 Neuester Beitrag: 25.04.21 00:45 | ||||
Eröffnet am: | 08.11.17 11:26 | von: Skyliner1992 | Anzahl Beiträge: | 526 |
Neuester Beitrag: | 25.04.21 00:45 | von: Brigitteaicta | Leser gesamt: | 165.520 |
Forum: | Hot-Stocks | Leser heute: | 3 | |
Bewertet mit: | ||||
Seite: < 1 | 2 | 3 | 4 | | 6 | 7 | 8 | 9 | ... 22 > |
Einer der wenigen Pennystocks in meinem Portfolio, 0,0x% vom Gesamtkapital.
Warte Korrektur ab, Zukauf mit charttechnischem Signal. nmM ;-)
Ownership
http://www.nasdaq.com/symbol/ptn/ownership-summary
Palatin Technologies, Inc. ( PTN ) is reporting for the quarter ending September 30, 2017. The consensus earnings per share forecast from the 1 analyst that follows the stock is $0.06. PTN reported earnings of $-0.08 per share for the same quarter a year ago; representing a a decrease of -175.00%.
Quelle: http://www.nasdaq.com/article/...ptn-asur-rdhl-cyrn-tst-fcsc-cm875734
Einschätzung PTN durch Motley
Motley Fool Guru Analysis for Palatin Technologies, Inc.
http://www.nasdaq.com/symbol/ptn/guru-analysis/fool
Strong sell? Hat jemand Info?
Palatin Technologies, Inc. (PTN - Free Report) is a developer of receptor specific peptide therapeutics for treating a variety of diseases in the United States. Palatin Technologies has a Zacks Rank #2 (Buy) and its expected earnings growth for the current year is more than 100%.
https://www.zacks.com/stock/news/280799/...ks-offering-strong-returns
Geschäftsgebäude von ptn sehen kann? Ich konnte bisher keinen sinnvollen entdecken.
hier der Firmensitz und Adresse
Palatin Technologies, Inc.
4-B Cedar Brook Drive
Cedar Brook Corporate Center
Cranbury, NJ 08512
https://www.palatin.com/contact-us/
https://www.google.com/maps/...c0212d&hl=de-DE&viewerState=ga
Cedar Brook offers executive office space tailored to suit a variety of tenant sizes with opportunities for future expansion, as well as chemistry and biology lab space to companies within the research, biotech, technology, pharma, manufacturing, electronic and life science sectors.
http://www.cedarbrooknj.com
Tenants at Cedar Brook Park and Eastpark
Our tenants include a mix of established companies and firms in life science, technology and R&D, including:
Cedar Brook Park Eastpark
Akorn Pharmaceuticals
Amicus Therapeutics
Ascensus
Bracco
CMIC CMO USA
Cornerstone Pharmaceuticals
Cranberry’s Gourmet Café
Endo Pharmaceuticals
Fisher Capital Corp LLC
Galderma R & D, LLC
Ipa / Hgp
Iris Id Systems, Inc.
Klus Pharma
Kronos Worldwide, Inc.
MJH Associates
Omnia Labs
Oncobiologics
Palatin Technologies
PMV Pharma
Porton USA
Purdue Pharma
Qualitest
Tulex Pharmaceuticals Inc.
Visionet
Wild Flavors
YoungTech
http://www.cedarbrooknj.com/tenants/